Literature DB >> 21229486

Risk factors for community-associated methicillin-resistant Staphylococcus aureus cellulitis--and the value of recognition.

Thana Khawcharoenporn1, Alan D Tice, Andrew Grandinetti, Dominic Chow.   

Abstract

OBJECTIVES: To identify the risk factors for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) cellulitis.
METHODS: A review of risk factors for CA-MRSA skin and soft tissue infection in previously published literature was first performed. A retrospective cohort study was then conducted in a teaching ambulatory-care clinic of a tertiary medical center in Honolulu, Hawaii.
RESULTS: Of 137 cases with cellulitis diagnosed from January 2005 to December 2007, MRSA was recovered from 85 (62%) of patients who presented with either abscesses or skin ulcers. The recovery of MRSA was significantly associated with obesity (p=0.01), presence of abscesses (p=0.01), and lesions involving the head and neck (p=0.04). Independent risk factors by multivariate logistic regression analysis included the presence of abscesses [adjusted odds ratio (aOR) 2.72; 95% confidence interval (CI) 1.27-5.83; p=0.01] and obesity (aOR 2.33; 95%; CI 1.10-4.97; p%0.03). Patients with CA-MRSA were less likely to receive an appropriate antibiotic (p=0.04) and were more likely to require antibiotic change at evaluation in one week (p=0.04) compared with patients infected with non-MRSA bacteria.
CONCLUSIONS: The presence of abscesses and obesity were significantly associated with CA-MRSA cellulitis. Empiric therapy with antibiotics active against MRSA should be guided by these risk factors. Hawaii Medical Journal Copyright 2010.

Entities:  

Mesh:

Year:  2010        PMID: 21229486      PMCID: PMC3071185     

Source DB:  PubMed          Journal:  Hawaii Med J        ISSN: 0017-8594


  18 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat.

Authors:  Nicola Zetola; John S Francis; Eric L Nuermberger; William R Bishai
Journal:  Lancet Infect Dis       Date:  2005-05       Impact factor: 25.071

3.  Community-associated MRSA--resistance and virulence converge.

Authors:  Henry F Chambers
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

4.  Community-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospital.

Authors:  Ghada N Al-Rawahi; Steve Reynolds; Susan D Porter; Leslie Forrester; Leane Kishi; Tiffany Chong; William R Bowie; Patrick W Doyle
Journal:  J Emerg Med       Date:  2008-03-06       Impact factor: 1.484

5.  Methicillin-resistant S. aureus infections among patients in the emergency department.

Authors:  Gregory J Moran; Anusha Krishnadasan; Rachel J Gorwitz; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; David A Talan
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

6.  Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men.

Authors:  Nolan E Lee; Melanie M Taylor; Elizabeth Bancroft; Peter J Ruane; Margie Morgan; Lucie McCoy; Paul A Simon
Journal:  Clin Infect Dis       Date:  2005-04-13       Impact factor: 9.079

7.  A clone of methicillin-resistant Staphylococcus aureus among professional football players.

Authors:  Sophia V Kazakova; Jeffrey C Hageman; Matthew Matava; Arjun Srinivasan; Larry Phelan; Bernard Garfinkel; Thomas Boo; Sigrid McAllister; Jim Anderson; Bette Jensen; Doug Dodson; David Lonsway; Linda K McDougal; Matthew Arduino; Victoria J Fraser; George Killgore; Fred C Tenover; Sara Cody; Daniel B Jernigan
Journal:  N Engl J Med       Date:  2005-02-03       Impact factor: 91.245

8.  Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002.

Authors:  Katherine M Campbell; Andrew F Vaughn; Kevin L Russell; Besa Smith; Dinice L Jimenez; Christopher P Barrozo; John R Minarcik; Nancy F Crum; Margaret A K Ryan
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

9.  Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections.

Authors:  Mark D King; Bianca J Humphrey; Yun F Wang; Ekaterina V Kourbatova; Susan M Ray; Henry M Blumberg
Journal:  Ann Intern Med       Date:  2006-03-07       Impact factor: 25.391

10.  Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002.

Authors:  Fenfang Li; Sarah Y Park; Tracy L Ayers; F DeWolfe Miller; Ralph MacFadden; Michele Nakata; Myra Ching Lee; Paul V Effler
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more
  8 in total

1.  Predictors of colonization with Staphylococcus species among patients scheduled for cardiac and orthopedic interventions at tertiary care hospitals in north-eastern Germany-a prevalence screening study.

Authors:  S Neidhart; S Zaatreh; A Klinder; S Redanz; R Spitzmüller; S Holtfreter; P Warnke; A Alozie; V Henck; A Göhler; M Ellenrieder; M AbouKoura; D Divchev; D Gümbel; M Napp; G Steinhoff; C Nienaber; A Ekkernkamp; W Mittelmeier; C Güthoff; A Podbielski; D Stengel; R Bader
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-21       Impact factor: 3.267

2.  Comparative Genomics Identifies Features Associated with Methicillin-Resistant Staphylococcus aureus (MRSA) Transmission in Hospital Settings.

Authors:  Timileyin Adedrian; Stephanie Hitchcock; Lyndsay M O'Hara; Jane M Michalski; J Kristie Johnson; David P Calfee; Loren G Miller; Tracy H Hazen; Anthony D Harris; David A Rasko
Journal:  mSphere       Date:  2022-05-17       Impact factor: 5.029

3.  A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001-2010.

Authors:  J A Casey; S E Cosgrove; W F Stewart; J Pollak; B S Schwartz
Journal:  Epidemiol Infect       Date:  2013-04-23       Impact factor: 2.451

4.  Incidence and factors associated with emergency department visits for recurrent skin and soft tissue infections in patients in California, 2005-2011.

Authors:  L May; E Y Klein; E M Martinez; N Mojica; L G Miller
Journal:  Epidemiol Infect       Date:  2016-12-05       Impact factor: 4.434

5.  Risk factors and complications of lower limb cellulitis in Africa: a systematic review.

Authors:  Frank-Leonel Tianyi; Clarence Mvalo Mbanga; Celestin Danwang; Valirie Ndip Agbor
Journal:  BMJ Open       Date:  2018-07-23       Impact factor: 2.692

6.  Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment.

Authors:  Julio Collazos; Belén de la Fuente; Alicia García; Helena Gómez; C Menéndez; Héctor Enríquez; Paula Sánchez; María Alonso; Ian López-Cruz; Manuel Martín-Regidor; Ana Martínez-Alonso; José Guerra; Arturo Artero; Marino Blanes; Javier de la Fuente; Víctor Asensi
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

7.  Factors associated with sepsis development in 606 Spanish adult patients with cellulitis.

Authors:  J Collazos; B de la Fuente; J de la Fuente; A García; H Gómez; C Menéndez; H Enríquez; P Sánchez; M Alonso; I López-Cruz; M Martín-Regidor; A Martínez-Alonso; J Guerra; A Artero; M Blanes; V Asensi
Journal:  BMC Infect Dis       Date:  2020-03-12       Impact factor: 3.090

8.  Microbiological, Clinical and Radiological Aspects of Diabetic Foot Ulcers Infected with Methicillin-Resistant and -Sensitive Staphylococcus aureus.

Authors:  Maria Stańkowska; Katarzyna Garbacz; Anna Korzon-Burakowska; Marek Bronk; Monika Skotarczak; Anna Szymańska-Dubowik
Journal:  Pathogens       Date:  2022-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.